NCT07870096Not yet recruitingPhase 1
Phase I/Ib Trial of Single Agent ITR-251 in Patients with Advanced Solid Tumors with an Expansion-Phase in Metastatic Castration-Resistant Prostate Cancer
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Oct 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- First submitted
- 14 Jul 2026
- Start date
- 1 Oct 2026
- Lead sponsor
- Iteria Biopharma S.L.
- Diseases
- Prostate cancer
- EU CT number
- 2026-527383-32-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 44
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Catala D'oncologia Coordinator of this site? Confirm its status | L'Hospitalet de Llobregat | Spain | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.